Ethyl Corp said its subsidiariescompleted the acquisiton of Nelson Research and Development Co
&lt;NELR>.
    The merger was approved following completion on Jan 27 of a
tender offer valued at approximately 55 mln dlrs, the company
said.
    It added that Nelson, based in Irvine, Calif., will be
operated as a wholly-owned subsidiary of Ethyl.
    Nelson designs and develops new drugs, Ethyl said.
 Reuter
